| 331 |
301: Binding, VEGF-A |
305: Inhibition, VegfR2 |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 332 |
302: Production, VEGF-A |
301: Binding, VEGF-A |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 333 |
302: Production, VEGF-A |
304: Decreased, VegfR2 |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 334 |
304: Decreased, VegfR2 |
305: Inhibition, VegfR2 |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 335 |
305: Inhibition, VegfR2 |
28: Reduction, Angiogenesis |
Nov 29, 2016 |
Jul 20, 2022 |
1 AOP
|
| 336 |
307: Increase, Vitellogenin synthesis in liver |
220: Increase, Plasma vitellogenin concentrations |
Nov 29, 2016 |
Jun 24, 2024 |
3 AOPs
|
| 337 |
309: Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development |
78: Reduction, Cumulative fecundity and spawning |
Nov 29, 2016 |
Mar 20, 2017 |
9 AOPs
|
| 338 |
310: Alteration, Wnt pathway |
240: Feminisation or incomplete development, Primary and accessory male sex organs |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 340 |
380: Activation, Pre-MIE: Metabolism of AFB1 |
373: Formation, Pro-mutagenic DNA Adducts |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 342 |
376: Increased, Induced Mutations in Critical Genes |
377: Increased, Proliferation/Clonal Expansion of Mutant Cells (Pre-Neoplastic Lesions/Altered H |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 343 |
377: Increased, Proliferation/Clonal Expansion of Mutant Cells (Pre-Neoplastic Lesions/Altered H |
378: Tumorigenesis, Hepatocellular carcinoma |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 344 |
373: Formation, Pro-mutagenic DNA Adducts |
377: Increased, Proliferation/Clonal Expansion of Mutant Cells (Pre-Neoplastic Lesions/Altered H |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 345 |
373: Formation, Pro-mutagenic DNA Adducts |
378: Tumorigenesis, Hepatocellular carcinoma |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 346 |
376: Increased, Induced Mutations in Critical Genes |
378: Tumorigenesis, Hepatocellular carcinoma |
Nov 29, 2016 |
Nov 30, 2016 |
1 AOP
|
| 347 |
52: Decreased, Calcium influx |
381: BDNF, Reduced |
Nov 29, 2016 |
Jun 13, 2018 |
2 AOPs
|
| 348 |
381: BDNF, Reduced |
382: Aberrant, Dendritic morphology |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 350 |
384: Increased, Clonal Expansion / Cell Proliferatin to form Pre-Neoplastic Altered Hepatic Foci |
378: Tumorigenesis, Hepatocellular carcinoma |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 351 |
376: Increased, Induced Mutations in Critical Genes |
384: Increased, Clonal Expansion / Cell Proliferatin to form Pre-Neoplastic Altered Hepatic Foci |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 352 |
373: Formation, Pro-mutagenic DNA Adducts |
384: Increased, Clonal Expansion / Cell Proliferatin to form Pre-Neoplastic Altered Hepatic Foci |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 353 |
381: BDNF, Reduced |
55: Cell injury/death |
Nov 29, 2016 |
Nov 29, 2016 |
2 AOPs
|
| 354 |
381: BDNF, Reduced |
383: Reduced, Presynaptic release of glutamate |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 355 |
55: Cell injury/death |
385: Synaptogenesis, Decreased |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 356 |
382: Aberrant, Dendritic morphology |
385: Synaptogenesis, Decreased |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 357 |
383: Reduced, Presynaptic release of glutamate |
385: Synaptogenesis, Decreased |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 358 |
385: Synaptogenesis, Decreased |
386: Neuronal network function, Decreased |
Nov 29, 2016 |
May 25, 2018 |
2 AOPs
|